RMDEF:OTCMKTS
Remedy Entertainment Oyj
20,00 USD
0,00%
(0,00) 1D
18-сен., 09:43:42 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RMDEF...
Mkt. cap
247,05 млн
Avg. vol.
5,00
Volume
46,00
52-wk high
20,00 USD
52-wk low
15,12 USD
Beta
0,16
Shares outstanding
13,64 млн
No. of employees
379
Mkt. cap
247,05 млн
Avg. vol.
5,00
Volume
46,00
52-wk high
20,00 USD
52-wk low
15,12 USD
Beta
0,16
Shares outstanding
13,64 млн
No. of employees
379
News stories
From web sources and news partners
Business Wire
·
44 мүнөт мурун
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall Street
·
17 мүнөт мурун
Halozyme Therapeutics (HALO) Brings Jim Daly Back To Its Board As Launch Focus Sharpens
MarketBeat
·
30 мүнөт мурун
PTC Therapeutics (NASDAQ:PTCT) Director Sells $781,920.00 in Stock
Profile
Remedy Entertainment Oyj, trading internationally as Remedy Entertainment Plc, is a Finnish video game developer based in Espoo. Notable games the studio has developed include the first two entries in the Max Payne franchise, Alan Wake, Quantum Break, and Control. Sam Lake, Remedy's creative director, has represented the company on numerous occasions.
Founded in August 1995 by members of demoscene group Future Crew, Remedy Entertainment created its first game, Death Rally, in a team member's basement. Apogee Software served as the game's publisher, and continued to be involved in the production of its next title, Max Payne, which received critical acclaim upon release. The game was followed by a sequel, Max Payne 2: The Fall of Max Payne, released by Rockstar Games. After spending seven years working on the Max Payne franchise, the developer decided to create a new intellectual property called Alan Wake. This title was once suspected to be vaporware because of the length of time it took to produce and release. It gained a cult following when it was released in 2010, by Microsoft Game Studios, though at the time its sales were not enough to justify the production of a sequel. Wikipedia
About Remedy Entertainment Oyj